Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 06 2020
Historique:
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 24 11 2020
Statut: epublish

Résumé

Human papillomavirus (HPV) infection is associated with oropharyngeal squamous cell carcinoma. International estimates suggest overall oral HPV prevalence is 7.5%, with prevalence of oral HPV types 16 and 18 being 1.6%; prior Australian estimates suggest oral HPV prevalence is 2.3%, with HPV-16 and HPV-18 being 1.3%. To estimate the prevalence of oral HPV infection among Indigenous Australians and to report the prevalence of factors associated with high-risk HPV types (ie, HPV-16 and HPV-18) and HPV types linked with Heck disease (ie, HPV-13 and HPV-32). This cross-sectional study analyzed HPV screening results from saliva samples collected from 1011 Indigenous Australians between February 2018 and January 2019. Data were analyzed from May 2018 to May 2019. Recruitment occurred through Aboriginal Community Controlled Health Organisations in South Australia. Eligibility included identifying as Indigenous, residing in South Australia, and being aged 18 years or older. Saliva samples were collected, with microbial DNA for genotyping extracted. Sociodemographic parameters, health-related behaviors, and sexual history data were collected. Analyses were stratified by sex as well as by HPV types 13 and 32 (Heck disease) and 16 and 18 (high risk of oropharyngeal squamous cell carcinoma). Multivariable analyses were conducted to obtain adjusted odds ratios (ORs). Data were obtained for 910 participants (median [interquartile range] age, 37 [27-51] years); 595 participants (65%) were female and 572 (63%) resided in nonmetropolitan locations. In all, 321 saliva samples (35.3%; 95% CI, 32.2%-38.4%) were positive for oral HPV (106 [33.7%] men; 215 [36.1%] women). The highest prevalence was found for HPV types 13 and 32 (207 [22.7%] total; 60 [19.0%] men; 147 [24.7%] women) followed by HPV types 16 and 18 (30 [3.3%] total; 9 [2.9%] men; 21 [3.5%] women). After multivariable analysis, risk factors associated with HPV types 13 and 32 included nonmetropolitan residential status (OR, 2.06; 95% CI, 1.10-3.88) and not having had a tonsillectomy (OR, 2.74; 95% CI, 1.05-7.16). Among women, having obtained a high school education or less was associated with lower odds of HPV-16 and HPV-18 infection (OR, 0.16; 95% CI, 0.03-0.97). Prevalence of oral HPV infection in a large sample of Indigenous Australians was high, with one-third testing positive. The most prevalent HPV types were those associated with Heck disease. The prevalence of HPV types associated with oropharyngeal squamous cell carcinoma exceeded both Australian and international population-level estimates.

Identifiants

pubmed: 32511719
pii: 2766818
doi: 10.1001/jamanetworkopen.2020.4951
pmc: PMC7280951
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e204951

Références

Med J Aust. 2019 Jul;211(1):31-36
pubmed: 31179546
Head Neck. 2016 May;38(5):743-50
pubmed: 25521312
N Engl J Med. 2007 May 10;356(19):1944-56
pubmed: 17494927
J Natl Cancer Inst. 2016 Jan 28;108(6):djv403
pubmed: 26823521
J Med Virol. 1995 Jun;46(2):97-102
pubmed: 7636509
Aust Dent J. 2019 Mar;64(1):11-18
pubmed: 30238467
PLoS One. 2014 Mar 17;9(3):e91761
pubmed: 24637512
Eur J Dermatol. 2000 Jul-Aug;10(5):395-7
pubmed: 10882951
Int J Dermatol. 2017 Dec;56(12):1414-1420
pubmed: 28791692
JMIR Res Protoc. 2018 Jun 08;7(6):e10503
pubmed: 29884604
Aust N Z J Obstet Gynaecol. 2012 Dec;52(6):528-33
pubmed: 23046059
J Oral Pathol Med. 1989 Aug;18(7):419-21
pubmed: 2555479
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
Cancer Epidemiol. 2017 Jun;48:131-139
pubmed: 28511150
Am J Mens Health. 2019 Jan-Feb;13(1):1557988319832120
pubmed: 30789079
Lancet. 2019 May 25;393(10186):2123
pubmed: 31226048
BMC Med. 2011 Sep 13;9:104
pubmed: 21910918
Eur J Oral Sci. 2018 Oct;126 Suppl 1:49-66
pubmed: 30178562
Oral Dis. 2004 Jul;10(4):240-3
pubmed: 15196147
Child Care Pract. 2018 Feb 08;24(2):164-180
pubmed: 29503596
Lancet. 2013 Sep 7;382(9895):877-87
pubmed: 23827089
J Gen Virol. 2017 Apr;98(4):519-526
pubmed: 28150575
J Maxillofac Oral Surg. 2011 Dec;10(4):357-60
pubmed: 23204755
Sex Health. 2014 Nov;11(5):416-26
pubmed: 25376995
Int J Dermatol. 2005 Apr;44(4):274-9
pubmed: 15811076
Curr Opin Otolaryngol Head Neck Surg. 2019 Apr;27(2):85-90
pubmed: 30694913
Oral Surg Oral Med Oral Pathol. 1965 Aug;20:201-12
pubmed: 14322615
Pediatr Dermatol. 2009 Jan-Feb;26(1):87-9
pubmed: 19250415
Arch Dermatol. 2004 Oct;140(10):1227-31
pubmed: 15492185

Auteurs

Lisa M Jamieson (LM)

Australian Research Centre for Population Oral Health, University of Adelaide, Adelaide, Australia.

Annika Antonsson (A)

QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia.

Gail Garvey (G)

Menzies School of Health Research, Spring Hill, Australia.

Xiangqun Ju (X)

Australian Research Centre for Population Oral Health, University of Adelaide, Adelaide, Australia.

Megan Smith (M)

Cancer Council New South Wales, Sydney, Australia.
Sydney Medical School, University of Sydney, Sydney, Australia.

Richard M Logan (RM)

Adelaide Dental School, University of Adelaide, Australia.

Newell W Johnson (NW)

Menzies Health Institute Queensland, Griffith University and Faculty of Dentistry, Queensland, Australia.
Oral and Craniofacial Sciences, King's College, London, United Kingdom.

Joanne Hedges (J)

Australian Research Centre for Population Oral Health, University of Adelaide, Adelaide, Australia.

Sneha Sethi (S)

Australian Research Centre for Population Oral Health, University of Adelaide, Adelaide, Australia.

Terry Dunbar (T)

National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, Australian National University, Australian Capital Territory, Australia.

Cathy Leane (C)

Strategic Partnerships, Aboriginal Health Division Women's and Children's Health Network, Adelaide, Adelaide, Australia.

Isaac Hill (I)

Aboriginal Health Council of South Australia, Adelaide, Australia.

Alex Brown (A)

Wardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, Australia.

David Roder (D)

University of South Australia School of Health Sciences, Adelaide, Australia.

Marjorie De Souza (M)

QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia.

Karen Canfell (K)

Cancer Council New South Wales, Sydney, Australia.
Sydney Medical School, University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH